FXH

First Trust Health Care AlphaDEX Fund

Down$82.32
$-1.10
(-1.32%)
As of 5:10:00 PM EDT | 12/09/19  |  Market Closed

FXH Trading Data

Open

$83.54

Low Price

$82.32

High Price

$83.54

Previous Last Price

$83.42

Bid Size

$81.96 X 1200

Ask Size

$98.59 X 100

FXH Portfolio Data

AUM

$1,149,669,000

Shares

13,900

PE Ratio

23.17

Price / Book Ratio

3.52

Expense Ratio

0.63

Net Asset Value

$82.71

Volume

Volume

35,405

Avg. Volume (YDT)

200,099

Dollar Volume

$2,555,679

Weekly Avg. Volume

70,601

Monthly Avg. Volume

94,670

Quarterly Avg. Volume

82,825

FXH Fund Description

The First Trust Health Care AlphaDEX Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant Health Care Index. The gross expense ratio for this fund is 0.61%. Expenses are capped contractually at 0.70% per year, at least until November 30, 2017.

FXH Chart

FXH Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust Health Care AlphaDEX Fund

Inception Date

2007-05-08

Asset Class

Equity

Asset Class Size

Biotech

FXH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

FXH Holdings

Top 10 Holdings

Seattle Genetics Inc. (SGEN)
2.73%
Biogen Inc. (BIIB)
2.56%
Molina Healthcare Inc. (MOH)
2.4%
Horizon Therapeutics Plc (HZNP)
2.33%
Jazz Pharmaceuticals Plc (JAZZ)
2.3%
DexCom Inc. (DXCM)
2.27%
MEDNAX Inc. (MD)
2.23%
Insulet Corporation (PODD)
2.22%
Bio-Rad Laboratories Inc. (Class A) (BIO)
2.21%
ResMed Inc. (RMD)
2.21%

Total FXH Holdings

Total Holdings: 81

Seattle Genetics Inc. (SGEN)
2.73%
Biogen Inc. (BIIB)
2.56%
Molina Healthcare Inc. (MOH)
2.4%
Horizon Therapeutics Plc (HZNP)
2.33%
Jazz Pharmaceuticals Plc (JAZZ)
2.3%
DexCom Inc. (DXCM)
2.27%
MEDNAX Inc. (MD)
2.23%
Insulet Corporation (PODD)
2.22%
Bio-Rad Laboratories Inc. (Class A) (BIO)
2.21%
ResMed Inc. (RMD)
2.21%
Edwards Lifesciences Corporation (EW)
2.2%
Alexion Pharmaceuticals Inc. (ALXN)
2.18%
Centene Corporation (CNC)
2.07%
Chemed Corporation (CHE)
2.06%
Humana Inc. (HUM)
2.02%
Regeneron Pharmaceuticals Inc. (REGN)
1.98%
Exelixis Inc. (EXEL)
1.93%
Cigna Corporation (CI)
1.92%
Zoetis Inc. (ZTS)
1.92%
Mylan N.V. (MYL)
1.9%
Bristol-Myers Squibb Company (BMY)
1.75%
Cardinal Health Inc. (CAH)
1.72%
Pfizer Inc. (PFE)
1.58%
Teleflex Incorporated (TFX)
1.57%
Gilead Sciences Inc. (GILD)
1.55%
West Pharmaceutical Services Inc. (WST)
1.55%
McKesson Corporation (MCK)
1.54%
DaVita Inc. (DVA)
1.52%
Laboratory Corporation of America Holdings (LH)
1.52%
WellCare Health Plans Inc. (WCG)
1.48%
Amgen Inc. (AMGN)
1.44%
Anthem Inc. (ANTM)
1.42%
Universal Health Services Inc. (Class B) (UHS)
1.42%
Veeva Systems Inc. (Class A) (VEEV)
1.42%
HCA Healthcare Inc. (HCA)
1.4%
Stryker Corporation (SYK)
1.4%
Bruker Corporation (BRKR)
1.36%
Thermo Fisher Scientific Inc. (TMO)
1.3%
Johnson & Johnson (JNJ)
1.29%
Agilent Technologies Inc. (A)
1.27%
AmerisourceBergen Corporation (ABC)
1.27%
Steris Plc (STE)
1.26%
Hologic Inc. (HOLX)
1.24%
Danaher Corporation (DHR)
1.22%
Quest Diagnostics Incorporated (DGX)
1.18%
IDEXX Laboratories Inc. (IDXX)
1.11%
Premier Inc. (Class A) (PINC)
0.99%
Neurocrine Biosciences Inc. (NBIX)
0.96%
QIAGEN N.V. (QGEN)
0.95%
Encompass Health Corporation (EHC)
0.84%
Charles River Laboratories International Inc. (CRL)
0.82%
Merck & Co. Inc. (MRK)
0.79%
The Cooper Companies Inc. (COO)
0.79%
Masimo Corporation (MASI)
0.78%
Cerner Corporation (CERN)
0.77%
Medtronic Plc (MDT)
0.77%
Abbott Laboratories (ABT)
0.76%
Becton Dickinson and Company (BDX)
0.76%
Hill-Rom Holdings Inc. (HRC)
0.76%
IQVIA Holdings Inc. (IQV)
0.73%
Baxter International Inc. (BAX)
0.7%
Perrigo Company Plc (PRGO)
0.69%
UnitedHealth Group Incorporated (UNH)
0.48%
Incyte Corporation (INCY)
0.47%
Varian Medical Systems Inc. (VAR)
0.44%
AbbVie Inc. (ABBV)
0.43%
ICU Medical Inc. (ICUI)
0.43%
Bio-Techne Corporation (TECH)
0.42%
PerkinElmer Inc. (PKI)
0.41%
PRA Health Sciences Inc. (PRAH)
0.41%
Boston Scientific Corporation (BSX)
0.4%
Catalent Inc. (CTLT)
0.4%
Eli Lilly and Company (LLY)
0.4%
Intuitive Surgical Inc. (ISRG)
0.4%
Ionis Pharmaceuticals Inc. (IONS)
0.4%
Cantel Medical Corp. (CMD)
0.39%
Elanco Animal Health Incorporated (ELAN)
0.38%
Exact Sciences Corporation (EXAS)
0.35%
Morgan Stanley Institutional Liquidity Fund - Treasury Portfolio (MISXX)
0.11%
US Dollar ($USD)
0.04%
First Trust Health Care AlphaDEX ETF (FXH)
0%

FXH Technicals

Alpha

-3.04

Beta

1.04

Leverage

Long

Standard Deviation

2.49

FXH Dividends

Dividend Date

2013-06-21

Latest Dividend

0.0055

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FXH Performance

YTD Return

19.53%

1 Year Return

11.86%

3 Year Return

43.83%

5 Year Return

39.52%

10 Year Return

286.02%

FXH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.